Search

Revvity Inc

Gesloten

SectorGezondheidszorg

120.9 -2.37

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

120.52

Max

123.8

Belangrijke statistieken

By Trading Economics

Inkomsten

13M

53M

Verkoop

19M

730M

K/W

Sectorgemiddelde

62.606

56.597

EPS

1.41

Dividendrendement

0.21

Winstmarge

7.329

Werknemers

11,000

EBITDA

8.8M

189M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+1.82% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

0.21%

2.18%

Volgende Winsten

26 okt 2026

Volgende dividenddatum

13 nov 2026

Volgende Ex Dividend datum

23 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.7B

15B

Vorige openingsprijs

123.27

Vorige sluitingsprijs

120.9

Nieuwssentiment

By Acuity

13%

87%

13 / 339 Rangschikking in Healthcare

Revvity Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

9 sep 2026, 20:07 UTC

News
Event

Revvity Inc announced its acquisition of Human Cell Design to enhance its Life Sciences portfolio. Shares are trading lower amid broader market weakness.

8 sep 2026, 20:07 UTC

Revvity Inc shares are lower today, continuing a decline since Friday's close. The stock opened down and remained weak throughout the session.

4 sep 2026, 19:47 UTC

News

Revvity Inc shares are lower amid mixed analyst ratings and price target adjustments. Earlier, shares pulled back from a session high during ongoing market volatility.

3 sep 2026, 20:07 UTC

News

Revvity Inc shares are lower today, reaching a low of -2.18%. Analyst Catherine Ramsey Schulte raised the price target to $144.00 from $131.00.

2 sep 2026, 21:02 UTC

Revvity Inc shares are higher in after-market trading, with no specific news identified. The broader market context includes a disappointing ADP employment report.

1 sep 2026, 19:43 UTC

News

Revvity shares are lower as RBC Capital initiates coverage with a Sector Perform rating and a price target of $135.

31 aug 2026, 20:07 UTC

Revvity Inc shares are lower amid broader market reactions to inflation comments from Warsh at the Jackson Hole Economic Symposium.

28 aug 2026, 22:51 UTC

Revvity Inc shares are trading lower in after-market hours. No specific news was identified to explain this movement amid overall weak market performance.

27 aug 2026, 20:07 UTC

Revvity Inc shares are higher, continuing a trend of gains since Wednesday. The stock remains above its 20-day moving average with four consecutive higher closes.

26 aug 2026, 19:16 UTC

Revvity Inc shares are higher, supported by strong performance metrics and trading above the 20-day moving average. No specific news was identified for this move.

25 aug 2026, 21:02 UTC

Revvity Inc. shares are trading lower in after-market hours, despite remaining above their 20-day moving average and near the upper end of their one-month range.

24 aug 2026, 19:56 UTC

Revvity Inc. shares are lower today, having reached a session low earlier. Broader market pressures include economic concerns related to U.S.-Iran relations.

21 aug 2026, 23:51 UTC

Revvity Inc shares are trading lower in after-market hours. The decline follows a consistent downward trend since Friday's close, despite remaining above the 20-day moving average.

20 aug 2026, 22:01 UTC

Revvity Inc shares are lower in after-market trading, continuing a decline since Thursday's close, despite being above its 20-day moving average.

19 aug 2026, 23:11 UTC

Revvity Inc shares are higher in after-market trading, maintaining gains above the 20-day moving average and near the top of their one-month range.

17 aug 2026, 19:46 UTC

News

RVTY shares lower after analyst downgrades from JPMorgan, Stifel.

14 aug 2026, 20:13 UTC

Revvity Inc shares are lower in after-market trading, with no specific news driving the decline. Broader market trends include a drop in U.S. retail sales.

13 aug 2026, 19:46 UTC

News

Revvity shares are lower despite Q2 revenue and non-GAAP earnings growth. Analysts raised concerns about segment dynamics and competitive challenges following the earnings report.

12 aug 2026, 19:46 UTC

Revvity Inc shares are higher today, supported by positive market sentiment following a favorable inflation report and strong quarterly results from technology companies.

11 aug 2026, 20:13 UTC

Revvity Inc. shares are trading roughly flat after-market hours, with market sentiment influenced by expectations for the upcoming Consumer Price Index report.

10 aug 2026, 22:01 UTC

Revvity Inc shares are trading higher in after-market hours, following broader market dynamics and reduced expectations for Federal Reserve rate hikes.

7 aug 2026, 19:46 UTC

Revvity Inc shares are higher today, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

6 aug 2026, 20:51 UTC

Revvity Inc shares are lower in after-market hours, with no specific news identified. The asset remains above its 20-day moving average.

5 aug 2026, 19:52 UTC

News

Revvity Inc shares are higher as Evercore ISI raises its price target to $126, supported by strong quarterly performance and increased guidance.

4 aug 2026, 19:51 UTC

Social Media
News

Revvity Inc shares are lower following second-quarter results that showed organic revenue growth of 3% and a slight miss on overall revenue estimates.

3 aug 2026, 19:44 UTC

News

Revvity Inc shares are higher ahead of tomorrow's earnings report, with analysts projecting a 3.9% revenue growth year-on-year, recovering from last year's decline.

31 jul 2026, 19:16 UTC

Revvity Inc shares are lower today amid broader market declines, influenced by rising yields and inflation concerns following a significant increase in crude oil prices.

29 jul 2026, 20:08 UTC

Revvity Inc shares are higher today, reflecting a steady upward trend amid rising oil prices and broader market influences. The stock is near its one-month range high.

28 jul 2026, 20:03 UTC

Revvity Inc shares are higher during Tuesday's session, continuing their advance since Monday's close, despite broader market weakness in Asian indices.

27 jul 2026, 21:02 UTC

Revvity Inc shares are lower in after-market hours, continuing a downward trend with three consecutive daily declines. No specific news was identified for the movement.

Peer Vergelijking

Prijswijziging

Revvity Inc Prognose

Koersdoel

By TipRanks

1.82% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 126.1 USD  1.82%

Hoogste 165 USD

Laagste 110 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Revvity Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

4

Buy

7

Hold

0

Sell

Sentiment

By Acuity

13 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat